Regulatory factor X-5/SCL/TAL1 interruption site axis promotes aerobic glycolysis and hepatocellular carcinoma cell stemness. [PDF]
Kaohsiung J Med SciZhang ZZ +5 more
europepmc +1 more source
Discussion of talks from the symposium: Factor X: From thrombokinase to oral anti-coagulants and beyond. [PDF]
J Thromb Thrombolysis, 2021 Milstone LM +8 more
europepmc +1 more source
Characterization of amino‐terminal fragment liberated from bovine prothrombin by activated factor X
, 1973 Takashi Morita +3 more
openalex +1 more source
On the Activation of Factor X-Activator of the Russell’s Viper-Venom by Calcium [PDF]
, 1977 Bidyut Baran Nath, Swapan Chattopadhyay
openalex +1 more source
Molecular Oncology, EarlyView.This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian +10 more
wiley +1 more source
miR-3064-5p and miR-4745-5p affect heparin sensitivity in patients undergoing cardiac surgery by regulating AT-III and factor X mRNA levels. [PDF]
Front Physiol, 2022 Ma HP +6 more
europepmc +1 more source
Plasma high density lipoproteins inhibit the activation of coagulation factor X by factor VIIa and tissue factor [PDF]
, 1981 Steven D. Carson
openalex +1 more source
YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma
Molecular Oncology, EarlyView.The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy +9 more
wiley +1 more source